Free tool
FAERS Monitor: Opfolda
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215211 or its brand name (Opfolda, Miglustat). Reports on generic versions are filed under their own applications.
Reports
264
Serious
186
70% of reports
Hospitalization
105
Death reported
30
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pneumonia24
- seizure24
- diarrhoea20
- vomiting15
- off label use14
- nausea12
- pyrexia12
- asthenia11
- condition aggravated11
- fatigue11
- respiratory failure11
- weight decreased11
- dysphagia10
- dyspnoea10
- fall10
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 3 |
| 2017 | 1 |
| 2018 | 10 |
| 2019 | 12 |
| 2020 | 11 |
| 2021 | 16 |
| 2022 | 18 |
| 2023 | 21 |
| 2024 | 51 |
| 2025 | 64 |
| 2026 | 48 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,895 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| seizureSignal | 24 | 16.6 | 11.3 | 337 |
| respiratory failureSignal | 11 | 12.0 | 6.7 | 101 |
| dysphagiaSignal | 10 | 8.4 | 4.6 | 58 |
| pneumoniaSignal | 24 | 5.9 | 4.0 | 94 |
| weight decreasedSignal | 11 | 3.1 | 1.8 | 14 |
| condition aggravatedSignal | 11 | 2.9 | 1.6 | 12 |
| pyrexiaSignal | 12 | 2.8 | 1.6 | 12 |
| vomitingSignal | 15 | 2.5 | 1.6 | 13 |
| diarrhoeaSignal | 20 | 2.5 | 1.6 | 17 |
| fallSignal | 10 | 2.4 | 1.3 | 7 |
| astheniaSignal | 11 | 2.3 | 1.3 | 7 |
| dyspnoea | 10 | 1.4 | 0.8 | 1 |
| off label use | 14 | 1.3 | 0.8 | 1 |
| nausea | 12 | 1.2 | 0.7 | 0 |
| fatigue | 11 | 1.1 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.